NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Health / Surgery
Agency / Source: Crutchfield Dermatology

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Crutchfield Dermatology Reports Continued Success with the New LipoDissolve Ultra - Lipodissolve Ultra is a new and special type of Mesotherapy that is a highly effective, non-surgical technique to reduce/eliminate unwanted deposits of fat (adipose tissue) with little or no downtime Developed exclusively at Crutchfield Dermatology
Crutchfield Dermatology Reports Continued Success with the New LipoDissolve Ultra

 

NewswireTODAY - /newswire/ - Eagan, MN, United States, 2008/01/28 - Lipodissolve Ultra is a new and special type of Mesotherapy that is a highly effective, non-surgical technique to reduce/eliminate unwanted deposits of fat (adipose tissue) with little or no downtime Developed exclusively at Crutchfield Dermatology.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

“Crutchfield Dermatology reports continued success with the new LipoDissolve Ultra: A superior improvement on standard LipoDissolve treatments”

LipoDissolve is a minimally invasive medical procedure that breaks down fat cells in specific areas of the body. Small amounts of lecithin, a soy bean extract (commonly used as an emulsifying agent in chocolate bars), are injected into unwanted areas of fat such as the tummy, love handles, double chins and saddle bags. This will cause the fat cells to dissolve and the body’s natural cleansing system metabolizes and eliminates the waste products out of the system. We report a new and improved advancement in the standard LipoDissolve treatment protocol where we use ultrasound massage both before and after Lipodissolve treatments for much better results. We call this “LipoDissoplve Ultra.”

The technique has become increasingly popular in the United States over recent years. LipoDissolve is a specific type of treatment known generally as ‘Mesotherapy’ that was first developed in France in the 1950’s. We report a new and improved variation in the standard LipoDissolve treatment protocol in which ultrasound massage is used both before and after Lipodissolve treatments for much better results.”

“LipoDissolve Ultra is like liposuction without surgery,” comments Charles E. Crutchfield III, MD, associate professor of dermatology at the University of Minnesota Medical School and medical director of Crutchfield Dermatology in Eagan, Minnesota. The FDA has not officially approved this treatment but it is currently under investigation. “I employ this formula on unwanted areas of fat, especially those that have not responded to diet and exercise. For the reduction of unwanted fat, the success rate approaches 90%.”

“I have developed a new protocol that employs ultrasound massage both before and after the LipoDissolve treatments. Some LipoDissolve practitioners use ultrasound before, some after, and some not at all. We are the first to report employing ultrasound massage both before and after LipoDissolve treatments. When ultrasound is used before, it make the adipose tissue more receptive the treatments, and when ultrasound is used after the treatments, it makes sure that the solution is distributed evenly, reduces post-treatment edema, and increases patient comfort. The downside is that by using the ultrasound before and after, it greatly increases the time required for a treatment, but our new protocol, LipoDissolve Ultra, is producing superior results compared to the traditional LipoDissolve and Mesotherapy treatments”, comments Dr. Crutchfield.

“LipoDissolve Ultra can be used in conjunction with liposuction for better body contouring. It can also be a good way of 'touching up' unevenly treated areas after having a liposuction procedure. LipoDissolve Ultra is a terrific treatment for localized areas of unwanted fat. Similar to liposuction, it is not a substitute for diet, exercise and overall weight reduction. The results can be very, very impressive.”

Charles E. Crutchfield III, M.D. (crutchfielddermatology.com) is one of North America’s leading experts in LipoDissolve and Mesotherapy. Dr. Crutchfield is a graduate of the Mayo Clinic Medical School, Clinical Associate Professor of Dermatology at the University of Minnesota Medical School, and Medical Director of Crutchfield Dermatology in Minneapolis/St. Paul (Eagan), Minnesota. He has written over 100 scientific and medical articles and has co-authored a textbook of dermatology. Dr. Crutchfield has been selected as one of the “Best Doctors in America” by his peers, an honor bestowed on only 4% of all practicing physicians. Dr. Crutchfield is an excellent interview and will engage and educate you and your audience.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Crutchfield Dermatology

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health / Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Crutchfield Dermatology Reports Continued Success with the New LipoDissolve Ultra

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Charles Crutchfield - CrutchfieldDermatology.com 
651-209-3600 charles[.]crutchfielddermatology.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Crutchfield Dermatology securities in any jurisdiction including any other companies listed or named in this release.

Health / Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Crutchfield Dermatology / Company Profile


Read Health / Surgery Most Recent Related Newswires:

DrFirst Recognized for Enabling Technology Leadership in Healthcare by Frost & Sullivan
NEC Orchestrating Future Fund Invests in Aetion, A U.S.-based Provider of Healthcare Analytics Platforms
Withings in Partnership with The French Government Invests €20.7M in Technical Innovation and AI to Propel Preventative Digital Healthcare
NEC and NEC Bio Publish Foundational Work on T Cell Receptor Engineering Using Proprietary Generative AI
RapidAI Applauded by Frost & Sullivan for Enhancing the Quality, Accuracy, and Speed of Stroke Imaging Diagnostics and Treatment
LANXESS Unveils New Disinfectant to Counter Mpox Threat
VitalLife and Bumrungrad International Hospital in Thailand Launch NEC's FonesVisuas Test
Clinion Applauded by Frost & Sullivan for Enabling Interoperability and Continuity in Clinical Trials Management with its eClinical Solutions
GenieMD Awarded Frost & Sullivan’s 2024 Company of the Year Award for Pioneering Virtual Chronic Disease Management Solutions
Health Recovery Solutions (HRS) Applauded by Frost & Sullivan for Transforming Remote Care Delivery with its Clinically Enabled, Patient-centric RPM
Greenway Health Earns Frost & Sullivan’s 2023 North American Revenue Cycle Management Customer Value Leadership Award for Consistently Delivering Prod
Verista Awarded by Frost & Sullivan for Providing Next-Generation Compliance and Quality Management Solutions in the Life Sciences Industry
TeraRecon Applauded by Frost & Sullivan for Solving Time-related Challenges in Neurological Care and its Market-leading Position
Nagasaki University and NEC OncoImmunity Collaborate to Design Universal Vaccines Targeting Tropical Infectious Diseases
Subang Jaya Medical Centre Awarded Frost & Sullivan’s Company of the Year Award for the Third Consecutive Year

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Enciris Technologies

Visit  MANE Drink





 
  ©2005-2025 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)